Procyclidine Hydrochloride

盐酸丙环定

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProcyclidine Hydrochloride
Drug Alias Nameprocyclidinum盐酸酸丙氯拉嗪procyclidine盐酸普环啶prociclidina +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1955/07/27
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMonarch Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN04AA04